Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Baden, David; Wolgast, Nadine; Altrock, Philipp M. et al.
Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysisLANCET REGIONAL HEALTH-EUROPE. Bd. 59. 2025
Schmidt, Marcus; Hesse, Tobias; Hoffmann, Oliver et al.
Eribulin-Induced Peripheral Neuropathy in Locally Advanced or Metastatic Breast Cancer: Final Analysis of the Prospective Cohort IRENE StudyCANCERS. Bd. 17. H. 3. 2025
Theis, Susanne; Senyigit, Julide; Buechler, Britta et al.
Escalation, maintenance and abstention in oncology a new study design to identify how individual values of patients impact on the assessment of risks and benefits of novel therapeutic concepts in cases of gynaecological tumors and colorectal cancer: a study protocolFRONTIERS IN ONCOLOGY. Bd. 15. 2025
Cytera, C.; Baust, K.; Borgmann-Staudt, A. et al.
Evaluation and implementation of multidisciplinary, standardized, guideline-based long-term follow-up care for adult survivors of childhood cancer in Germany: protocol of a prospective, multi-center, nationwide study (LE-Na)BMC CANCER. Bd. 25. H. 1. 2025 S. 9
Klamminger, Gilbert Georg; Nigdelis, Meletios P.; Bitterlich, Annick et al.
Evaluation of podoplanin expression in vulvar squamous cell carcinoma and stromal fibroblasts and its prognostic implicationsSCIENTIFIC REPORTS. Bd. 15. H. 1. 2025
Klamminger, Gilbert Georg; Bitterlich, Annick; Hamoud, Bashar Haj et al.
Evaluation of Tumor Budding and Poorly Defined Clusters as Histological Biomarkers in Squamous Cell Carcinomas of the VulvaCANCERS. Bd. 17. H. 10. 2025
Klamminger, Gilbert Georg; Bitterlich, Annick; Hamoud, Bashar Haj et al.
Evaluation Of Tumor Budding, Poorly Defined Clusters, And Tumor-Stroma Ratio As Histological Biomarkers In Squamous Cell Carcinoma Of The VulvaINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 35. H. 2. 2025
Blomain, Erik S.; Soudi, Shaghayegh; Wang, Ziwei et al.
Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy ResponseCANCER RESEARCH. Bd. 85. H. 6. 2025 S. 1162-1174
El-Khoueiry, David; Balli, David; Blanc, Jean-Frederic et al.
Expanded biomarker analysis of an international, open-label phase 2 study of regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors (ICI).JOURNAL OF CLINICAL ONCOLOGY. Bd. 43. H. 4_SUPPL. 2025
Inci, Melisa Guelhan; Ilter, Ebru; Roser, Eva et al.
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 35. H. 10. 2025